Shah, N. A., S. Paul, S. Parveen, M. H. Bhat, I. Ali, and S. A. Kadla. “Therapeutic Outcome of Saroglitazar, a Peroxisome Proliferator Activated Receptor α/γ Agonist in Diabetic and Non-Diabetic Metabolic Dysfunction Associated Steatotic Liver Disease”. International Journal of Basic & Clinical Pharmacology, vol. 14, no. 4, June 2025, pp. 519-25, doi:10.18203/2319-2003.ijbcp20251836.